Ikarian Capital’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-283,464
| Closed | -$130K | – | 129 |
|
|
2023
Q2 | $130K | Hold |
283,464
| – | – | 0.02% | 75 |
|
|
2023
Q1 | $6.56M | Hold |
283,464
| – | – | 1.49% | 11 |
|
|
2022
Q4 | $0 | Hold |
283,464
| – | – | ﹤0.01% | 86 |
|
|
2022
Q3 | $0 | Sell |
283,464
-48,831
| -15% | – | ﹤0.01% | 135 |
|
|
2022
Q2 | $0 | Buy |
+332,295
| New | – | ﹤0.01% | 175 |
|
|
2020
Q3 | – | Sell |
-673,995
| Closed | -$7.79M | – | 162 |
|
|
2020
Q2 | $7.79M | Sell |
673,995
-53,605
| -7% | -$619K | 0.62% | 14 |
|
|
2020
Q1 | $9.97M | Buy |
727,600
+359,894
| +98% | +$4.93M | 0.75% | 7 |
|
|
2019
Q4 | $2.17M | Buy |
+367,706
| New | +$2.17M | 0.35% | 20 |
|